nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN2A—hematopoietic system—hematologic cancer	0.0067	0.0729	CbGeAlD
Phenazopyridine—SCN10A—hematopoietic system—hematologic cancer	0.00646	0.0703	CbGeAlD
Phenazopyridine—SCN7A—lung—hematologic cancer	0.00629	0.0684	CbGeAlD
Phenazopyridine—SCN7A—testis—hematologic cancer	0.00593	0.0646	CbGeAlD
Phenazopyridine—SCN8A—testis—hematologic cancer	0.00529	0.0576	CbGeAlD
Phenazopyridine—SCN9A—lung—hematologic cancer	0.00493	0.0536	CbGeAlD
Phenazopyridine—SCN9A—testis—hematologic cancer	0.00465	0.0506	CbGeAlD
Phenazopyridine—SCN2A—blood—hematologic cancer	0.00444	0.0483	CbGeAlD
Phenazopyridine—SCN7A—lymph node—hematologic cancer	0.0043	0.0468	CbGeAlD
Phenazopyridine—SCN10A—blood—hematologic cancer	0.00428	0.0466	CbGeAlD
Phenazopyridine—SCN1A—lung—hematologic cancer	0.00424	0.0461	CbGeAlD
Phenazopyridine—SCN4A—testis—hematologic cancer	0.00415	0.0451	CbGeAlD
Phenazopyridine—SCN3A—blood—hematologic cancer	0.0039	0.0424	CbGeAlD
Phenazopyridine—SCN5A—blood—hematologic cancer	0.00389	0.0423	CbGeAlD
Phenazopyridine—SCN3A—bone marrow—hematologic cancer	0.00377	0.0411	CbGeAlD
Phenazopyridine—SCN10A—lung—hematologic cancer	0.00375	0.0408	CbGeAlD
Phenazopyridine—SCN3A—lung—hematologic cancer	0.00342	0.0372	CbGeAlD
Phenazopyridine—SCN9A—lymph node—hematologic cancer	0.00337	0.0367	CbGeAlD
Phenazopyridine—SCN3A—testis—hematologic cancer	0.00322	0.0351	CbGeAlD
Phenazopyridine—SCN10A—lymph node—hematologic cancer	0.00256	0.0279	CbGeAlD
Phenazopyridine—SCN3A—lymph node—hematologic cancer	0.00234	0.0254	CbGeAlD
Phenazopyridine—Headache—Dasatinib—hematologic cancer	0.000896	0.00167	CcSEcCtD
Phenazopyridine—Headache—Bexarotene—hematologic cancer	0.000896	0.00167	CcSEcCtD
Phenazopyridine—Headache—Fludarabine—hematologic cancer	0.000894	0.00166	CcSEcCtD
Phenazopyridine—Nausea—Busulfan—hematologic cancer	0.000894	0.00166	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Vinorelbine—hematologic cancer	0.000889	0.00165	CcSEcCtD
Phenazopyridine—Diarrhoea—Cladribine—hematologic cancer	0.000884	0.00165	CcSEcCtD
Phenazopyridine—Hypersensitivity—Melphalan—hematologic cancer	0.000868	0.00162	CcSEcCtD
Phenazopyridine—Nausea—Procarbazine—hematologic cancer	0.000867	0.00161	CcSEcCtD
Phenazopyridine—Dyspepsia—Thiotepa—hematologic cancer	0.000865	0.00161	CcSEcCtD
Phenazopyridine—Vomiting—Chlorambucil—hematologic cancer	0.000859	0.0016	CcSEcCtD
Phenazopyridine—Nausea—Bexarotene—hematologic cancer	0.00085	0.00158	CcSEcCtD
Phenazopyridine—Nausea—Dasatinib—hematologic cancer	0.00085	0.00158	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Thiotepa—hematologic cancer	0.000849	0.00158	CcSEcCtD
Phenazopyridine—Nausea—Fludarabine—hematologic cancer	0.000847	0.00158	CcSEcCtD
Phenazopyridine—Diarrhoea—Vinblastine—hematologic cancer	0.000847	0.00158	CcSEcCtD
Phenazopyridine—Hypersensitivity—Lenalidomide—hematologic cancer	0.000844	0.00157	CcSEcCtD
Phenazopyridine—Vomiting—Nilotinib—hematologic cancer	0.00084	0.00156	CcSEcCtD
Phenazopyridine—Dyspepsia—Thalidomide—hematologic cancer	0.000837	0.00156	CcSEcCtD
Phenazopyridine—Vomiting—Imatinib—hematologic cancer	0.000836	0.00156	CcSEcCtD
Phenazopyridine—Pruritus—Melphalan—hematologic cancer	0.000833	0.00155	CcSEcCtD
Phenazopyridine—Rash—Nilotinib—hematologic cancer	0.000833	0.00155	CcSEcCtD
Phenazopyridine—Dermatitis—Nilotinib—hematologic cancer	0.000833	0.00155	CcSEcCtD
Phenazopyridine—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000832	0.00155	CcSEcCtD
Phenazopyridine—Rash—Imatinib—hematologic cancer	0.000829	0.00154	CcSEcCtD
Phenazopyridine—Headache—Nilotinib—hematologic cancer	0.000828	0.00154	CcSEcCtD
Phenazopyridine—Dermatitis—Imatinib—hematologic cancer	0.000828	0.00154	CcSEcCtD
Phenazopyridine—Headache—Imatinib—hematologic cancer	0.000823	0.00153	CcSEcCtD
Phenazopyridine—Vomiting—Cladribine—hematologic cancer	0.000821	0.00153	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000821	0.00153	CcSEcCtD
Phenazopyridine—Rash—Cladribine—hematologic cancer	0.000814	0.00152	CcSEcCtD
Phenazopyridine—Dermatitis—Cladribine—hematologic cancer	0.000813	0.00151	CcSEcCtD
Phenazopyridine—Pruritus—Lenalidomide—hematologic cancer	0.00081	0.00151	CcSEcCtD
Phenazopyridine—Headache—Cladribine—hematologic cancer	0.000809	0.00151	CcSEcCtD
Phenazopyridine—Diarrhoea—Melphalan—hematologic cancer	0.000806	0.0015	CcSEcCtD
Phenazopyridine—Nausea—Chlorambucil—hematologic cancer	0.000803	0.00149	CcSEcCtD
Phenazopyridine—Dyspepsia—Alitretinoin—hematologic cancer	0.000796	0.00148	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000788	0.00147	CcSEcCtD
Phenazopyridine—Visual impairment—Betamethasone—hematologic cancer	0.000788	0.00147	CcSEcCtD
Phenazopyridine—Visual impairment—Dexamethasone—hematologic cancer	0.000788	0.00147	CcSEcCtD
Phenazopyridine—Vomiting—Vinblastine—hematologic cancer	0.000787	0.00147	CcSEcCtD
Phenazopyridine—Nausea—Nilotinib—hematologic cancer	0.000785	0.00146	CcSEcCtD
Phenazopyridine—Diarrhoea—Lenalidomide—hematologic cancer	0.000784	0.00146	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000781	0.00145	CcSEcCtD
Phenazopyridine—Nausea—Imatinib—hematologic cancer	0.000781	0.00145	CcSEcCtD
Phenazopyridine—Hypersensitivity—Bortezomib—hematologic cancer	0.000777	0.00145	CcSEcCtD
Phenazopyridine—Headache—Vinblastine—hematologic cancer	0.000776	0.00144	CcSEcCtD
Phenazopyridine—Diarrhoea—Hydroxyurea—hematologic cancer	0.000773	0.00144	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000772	0.00144	CcSEcCtD
Phenazopyridine—Hypersensitivity—Bleomycin—hematologic cancer	0.000771	0.00144	CcSEcCtD
Phenazopyridine—Nausea—Cladribine—hematologic cancer	0.000767	0.00143	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vinorelbine—hematologic cancer	0.000758	0.00141	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000752	0.0014	CcSEcCtD
Phenazopyridine—Vomiting—Melphalan—hematologic cancer	0.000749	0.00139	CcSEcCtD
Phenazopyridine—Dyspepsia—Mitoxantrone—hematologic cancer	0.000747	0.00139	CcSEcCtD
Phenazopyridine—Dyspepsia—Irinotecan—hematologic cancer	0.000747	0.00139	CcSEcCtD
Phenazopyridine—Pruritus—Bortezomib—hematologic cancer	0.000746	0.00139	CcSEcCtD
Phenazopyridine—Rash—Melphalan—hematologic cancer	0.000743	0.00138	CcSEcCtD
Phenazopyridine—Dermatitis—Melphalan—hematologic cancer	0.000742	0.00138	CcSEcCtD
Phenazopyridine—Pruritus—Bleomycin—hematologic cancer	0.00074	0.00138	CcSEcCtD
Phenazopyridine—Nausea—Vinblastine—hematologic cancer	0.000736	0.00137	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000733	0.00136	CcSEcCtD
Phenazopyridine—Vomiting—Lenalidomide—hematologic cancer	0.000728	0.00136	CcSEcCtD
Phenazopyridine—Pruritus—Vinorelbine—hematologic cancer	0.000728	0.00136	CcSEcCtD
Phenazopyridine—Hypersensitivity—Thiotepa—hematologic cancer	0.000724	0.00135	CcSEcCtD
Phenazopyridine—Rash—Lenalidomide—hematologic cancer	0.000722	0.00134	CcSEcCtD
Phenazopyridine—Dermatitis—Lenalidomide—hematologic cancer	0.000722	0.00134	CcSEcCtD
Phenazopyridine—Diarrhoea—Bortezomib—hematologic cancer	0.000721	0.00134	CcSEcCtD
Phenazopyridine—Vomiting—Hydroxyurea—hematologic cancer	0.000718	0.00134	CcSEcCtD
Phenazopyridine—Headache—Lenalidomide—hematologic cancer	0.000718	0.00134	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000714	0.00133	CcSEcCtD
Phenazopyridine—Rash—Hydroxyurea—hematologic cancer	0.000712	0.00133	CcSEcCtD
Phenazopyridine—Dermatitis—Hydroxyurea—hematologic cancer	0.000711	0.00132	CcSEcCtD
Phenazopyridine—Headache—Hydroxyurea—hematologic cancer	0.000708	0.00132	CcSEcCtD
Phenazopyridine—Diarrhoea—Vinorelbine—hematologic cancer	0.000704	0.00131	CcSEcCtD
Phenazopyridine—Hypersensitivity—Thalidomide—hematologic cancer	0.0007	0.0013	CcSEcCtD
Phenazopyridine—Nausea—Melphalan—hematologic cancer	0.0007	0.0013	CcSEcCtD
Phenazopyridine—Pruritus—Thiotepa—hematologic cancer	0.000695	0.00129	CcSEcCtD
Phenazopyridine—Nausea—Lenalidomide—hematologic cancer	0.00068	0.00127	CcSEcCtD
Phenazopyridine—Hypersensitivity—Carmustine—hematologic cancer	0.000673	0.00125	CcSEcCtD
Phenazopyridine—Pruritus—Thalidomide—hematologic cancer	0.000673	0.00125	CcSEcCtD
Phenazopyridine—Diarrhoea—Thiotepa—hematologic cancer	0.000673	0.00125	CcSEcCtD
Phenazopyridine—Nausea—Hydroxyurea—hematologic cancer	0.000671	0.00125	CcSEcCtD
Phenazopyridine—Vomiting—Bortezomib—hematologic cancer	0.00067	0.00125	CcSEcCtD
Phenazopyridine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000666	0.00124	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.000665	0.00124	CcSEcCtD
Phenazopyridine—Vomiting—Bleomycin—hematologic cancer	0.000665	0.00124	CcSEcCtD
Phenazopyridine—Rash—Bortezomib—hematologic cancer	0.000665	0.00124	CcSEcCtD
Phenazopyridine—Dermatitis—Bortezomib—hematologic cancer	0.000664	0.00124	CcSEcCtD
Phenazopyridine—Headache—Bortezomib—hematologic cancer	0.00066	0.00123	CcSEcCtD
Phenazopyridine—Rash—Bleomycin—hematologic cancer	0.00066	0.00123	CcSEcCtD
Phenazopyridine—Dermatitis—Bleomycin—hematologic cancer	0.000659	0.00123	CcSEcCtD
Phenazopyridine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000659	0.00123	CcSEcCtD
Phenazopyridine—Vomiting—Vinorelbine—hematologic cancer	0.000654	0.00122	CcSEcCtD
Phenazopyridine—Diarrhoea—Thalidomide—hematologic cancer	0.00065	0.00121	CcSEcCtD
Phenazopyridine—Rash—Vinorelbine—hematologic cancer	0.000649	0.00121	CcSEcCtD
Phenazopyridine—Dermatitis—Vinorelbine—hematologic cancer	0.000648	0.00121	CcSEcCtD
Phenazopyridine—Headache—Vinorelbine—hematologic cancer	0.000645	0.0012	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vincristine—hematologic cancer	0.000642	0.0012	CcSEcCtD
Phenazopyridine—Pruritus—Alitretinoin—hematologic cancer	0.00064	0.00119	CcSEcCtD
Phenazopyridine—Pruritus—Ifosfamide—hematologic cancer	0.000632	0.00118	CcSEcCtD
Phenazopyridine—Nausea—Bortezomib—hematologic cancer	0.000626	0.00117	CcSEcCtD
Phenazopyridine—Hypersensitivity—Irinotecan—hematologic cancer	0.000625	0.00116	CcSEcCtD
Phenazopyridine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000625	0.00116	CcSEcCtD
Phenazopyridine—Vomiting—Thiotepa—hematologic cancer	0.000625	0.00116	CcSEcCtD
Phenazopyridine—Diarrhoea—Carmustine—hematologic cancer	0.000625	0.00116	CcSEcCtD
Phenazopyridine—Nausea—Bleomycin—hematologic cancer	0.000621	0.00116	CcSEcCtD
Phenazopyridine—Rash—Thiotepa—hematologic cancer	0.00062	0.00115	CcSEcCtD
Phenazopyridine—Dermatitis—Thiotepa—hematologic cancer	0.000619	0.00115	CcSEcCtD
Phenazopyridine—Diarrhoea—Alitretinoin—hematologic cancer	0.000619	0.00115	CcSEcCtD
Phenazopyridine—Headache—Thiotepa—hematologic cancer	0.000616	0.00115	CcSEcCtD
Phenazopyridine—Diarrhoea—Ifosfamide—hematologic cancer	0.000612	0.00114	CcSEcCtD
Phenazopyridine—Nausea—Vinorelbine—hematologic cancer	0.000611	0.00114	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Etoposide—hematologic cancer	0.00061	0.00114	CcSEcCtD
Phenazopyridine—Jaundice—Epirubicin—hematologic cancer	0.000605	0.00113	CcSEcCtD
Phenazopyridine—Vomiting—Thalidomide—hematologic cancer	0.000604	0.00113	CcSEcCtD
Phenazopyridine—Rash—Thalidomide—hematologic cancer	0.000599	0.00112	CcSEcCtD
Phenazopyridine—Dermatitis—Thalidomide—hematologic cancer	0.000599	0.00112	CcSEcCtD
Phenazopyridine—Diarrhoea—Vincristine—hematologic cancer	0.000596	0.00111	CcSEcCtD
Phenazopyridine—Headache—Thalidomide—hematologic cancer	0.000596	0.00111	CcSEcCtD
Phenazopyridine—Hepatitis—Methotrexate—hematologic cancer	0.000595	0.00111	CcSEcCtD
Phenazopyridine—Pruritus—Gemcitabine—hematologic cancer	0.000585	0.00109	CcSEcCtD
Phenazopyridine—Nausea—Thiotepa—hematologic cancer	0.000584	0.00109	CcSEcCtD
Phenazopyridine—Diarrhoea—Mitoxantrone—hematologic cancer	0.000581	0.00108	CcSEcCtD
Phenazopyridine—Diarrhoea—Irinotecan—hematologic cancer	0.000581	0.00108	CcSEcCtD
Phenazopyridine—Vomiting—Carmustine—hematologic cancer	0.000581	0.00108	CcSEcCtD
Phenazopyridine—Rash—Carmustine—hematologic cancer	0.000576	0.00107	CcSEcCtD
Phenazopyridine—Dermatitis—Carmustine—hematologic cancer	0.000575	0.00107	CcSEcCtD
Phenazopyridine—Vomiting—Alitretinoin—hematologic cancer	0.000575	0.00107	CcSEcCtD
Phenazopyridine—Visual impairment—Methotrexate—hematologic cancer	0.000574	0.00107	CcSEcCtD
Phenazopyridine—Headache—Carmustine—hematologic cancer	0.000572	0.00107	CcSEcCtD
Phenazopyridine—Rash—Alitretinoin—hematologic cancer	0.00057	0.00106	CcSEcCtD
Phenazopyridine—Dermatitis—Alitretinoin—hematologic cancer	0.00057	0.00106	CcSEcCtD
Phenazopyridine—Vomiting—Ifosfamide—hematologic cancer	0.000568	0.00106	CcSEcCtD
Phenazopyridine—Hypersensitivity—Cisplatin—hematologic cancer	0.000568	0.00106	CcSEcCtD
Phenazopyridine—Headache—Alitretinoin—hematologic cancer	0.000567	0.00106	CcSEcCtD
Phenazopyridine—Diarrhoea—Gemcitabine—hematologic cancer	0.000566	0.00105	CcSEcCtD
Phenazopyridine—Nausea—Thalidomide—hematologic cancer	0.000565	0.00105	CcSEcCtD
Phenazopyridine—Dyspepsia—Triamcinolone—hematologic cancer	0.000564	0.00105	CcSEcCtD
Phenazopyridine—Rash—Ifosfamide—hematologic cancer	0.000564	0.00105	CcSEcCtD
Phenazopyridine—Dermatitis—Ifosfamide—hematologic cancer	0.000563	0.00105	CcSEcCtD
Phenazopyridine—Jaundice—Doxorubicin—hematologic cancer	0.00056	0.00104	CcSEcCtD
Phenazopyridine—Hepatitis—Epirubicin—hematologic cancer	0.000557	0.00104	CcSEcCtD
Phenazopyridine—Vomiting—Vincristine—hematologic cancer	0.000554	0.00103	CcSEcCtD
Phenazopyridine—Rash—Vincristine—hematologic cancer	0.00055	0.00102	CcSEcCtD
Phenazopyridine—Dermatitis—Vincristine—hematologic cancer	0.000549	0.00102	CcSEcCtD
Phenazopyridine—Headache—Vincristine—hematologic cancer	0.000546	0.00102	CcSEcCtD
Phenazopyridine—Nausea—Carmustine—hematologic cancer	0.000542	0.00101	CcSEcCtD
Phenazopyridine—Vomiting—Irinotecan—hematologic cancer	0.00054	0.001	CcSEcCtD
Phenazopyridine—Vomiting—Mitoxantrone—hematologic cancer	0.00054	0.001	CcSEcCtD
Phenazopyridine—Nausea—Alitretinoin—hematologic cancer	0.000537	0.001	CcSEcCtD
Phenazopyridine—Visual impairment—Epirubicin—hematologic cancer	0.000537	0.001	CcSEcCtD
Phenazopyridine—Rash—Mitoxantrone—hematologic cancer	0.000535	0.000997	CcSEcCtD
Phenazopyridine—Rash—Irinotecan—hematologic cancer	0.000535	0.000997	CcSEcCtD
Phenazopyridine—Dermatitis—Irinotecan—hematologic cancer	0.000535	0.000996	CcSEcCtD
Phenazopyridine—Dermatitis—Mitoxantrone—hematologic cancer	0.000535	0.000996	CcSEcCtD
Phenazopyridine—Headache—Mitoxantrone—hematologic cancer	0.000532	0.00099	CcSEcCtD
Phenazopyridine—Headache—Irinotecan—hematologic cancer	0.000532	0.00099	CcSEcCtD
Phenazopyridine—Nausea—Ifosfamide—hematologic cancer	0.000531	0.000989	CcSEcCtD
Phenazopyridine—Diarrhoea—Cisplatin—hematologic cancer	0.000527	0.000982	CcSEcCtD
Phenazopyridine—Vomiting—Gemcitabine—hematologic cancer	0.000526	0.000979	CcSEcCtD
Phenazopyridine—Rash—Gemcitabine—hematologic cancer	0.000521	0.000971	CcSEcCtD
Phenazopyridine—Dermatitis—Gemcitabine—hematologic cancer	0.000521	0.00097	CcSEcCtD
Phenazopyridine—Hypersensitivity—Etoposide—hematologic cancer	0.00052	0.000969	CcSEcCtD
Phenazopyridine—Headache—Gemcitabine—hematologic cancer	0.000518	0.000965	CcSEcCtD
Phenazopyridine—Nausea—Vincristine—hematologic cancer	0.000518	0.000964	CcSEcCtD
Phenazopyridine—Hepatitis—Doxorubicin—hematologic cancer	0.000515	0.00096	CcSEcCtD
Phenazopyridine—Hypersensitivity—Prednisolone—hematologic cancer	0.000513	0.000955	CcSEcCtD
Phenazopyridine—Dyspepsia—Dexamethasone—hematologic cancer	0.000511	0.000952	CcSEcCtD
Phenazopyridine—Dyspepsia—Betamethasone—hematologic cancer	0.000511	0.000952	CcSEcCtD
Phenazopyridine—Nausea—Mitoxantrone—hematologic cancer	0.000504	0.000939	CcSEcCtD
Phenazopyridine—Nausea—Irinotecan—hematologic cancer	0.000504	0.000939	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000502	0.000934	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000502	0.000934	CcSEcCtD
Phenazopyridine—Pruritus—Etoposide—hematologic cancer	0.0005	0.00093	CcSEcCtD
Phenazopyridine—Visual impairment—Doxorubicin—hematologic cancer	0.000497	0.000925	CcSEcCtD
Phenazopyridine—Nausea—Gemcitabine—hematologic cancer	0.000491	0.000915	CcSEcCtD
Phenazopyridine—Vomiting—Cisplatin—hematologic cancer	0.00049	0.000912	CcSEcCtD
Phenazopyridine—Rash—Cisplatin—hematologic cancer	0.000486	0.000905	CcSEcCtD
Phenazopyridine—Dermatitis—Cisplatin—hematologic cancer	0.000485	0.000904	CcSEcCtD
Phenazopyridine—Diarrhoea—Etoposide—hematologic cancer	0.000483	0.0009	CcSEcCtD
Phenazopyridine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000472	0.000879	CcSEcCtD
Phenazopyridine—Nausea—Cisplatin—hematologic cancer	0.000458	0.000852	CcSEcCtD
Phenazopyridine—Pruritus—Triamcinolone—hematologic cancer	0.000453	0.000844	CcSEcCtD
Phenazopyridine—Vomiting—Etoposide—hematologic cancer	0.000449	0.000836	CcSEcCtD
Phenazopyridine—Dyspepsia—Prednisone—hematologic cancer	0.000445	0.000829	CcSEcCtD
Phenazopyridine—Rash—Etoposide—hematologic cancer	0.000445	0.000829	CcSEcCtD
Phenazopyridine—Dermatitis—Etoposide—hematologic cancer	0.000445	0.000828	CcSEcCtD
Phenazopyridine—Headache—Etoposide—hematologic cancer	0.000442	0.000824	CcSEcCtD
Phenazopyridine—Rash—Prednisolone—hematologic cancer	0.000439	0.000818	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisolone—hematologic cancer	0.000439	0.000817	CcSEcCtD
Phenazopyridine—Headache—Prednisolone—hematologic cancer	0.000436	0.000812	CcSEcCtD
Phenazopyridine—Nausea—Etoposide—hematologic cancer	0.000419	0.000781	CcSEcCtD
Phenazopyridine—Nausea—Prednisolone—hematologic cancer	0.000414	0.00077	CcSEcCtD
Phenazopyridine—Pruritus—Dexamethasone—hematologic cancer	0.000411	0.000766	CcSEcCtD
Phenazopyridine—Pruritus—Betamethasone—hematologic cancer	0.000411	0.000766	CcSEcCtD
Phenazopyridine—Vomiting—Triamcinolone—hematologic cancer	0.000407	0.000758	CcSEcCtD
Phenazopyridine—Rash—Triamcinolone—hematologic cancer	0.000404	0.000752	CcSEcCtD
Phenazopyridine—Dermatitis—Triamcinolone—hematologic cancer	0.000403	0.000751	CcSEcCtD
Phenazopyridine—Headache—Triamcinolone—hematologic cancer	0.000401	0.000747	CcSEcCtD
Phenazopyridine—Diarrhoea—Dexamethasone—hematologic cancer	0.000398	0.00074	CcSEcCtD
Phenazopyridine—Diarrhoea—Betamethasone—hematologic cancer	0.000398	0.00074	CcSEcCtD
Phenazopyridine—Nausea—Triamcinolone—hematologic cancer	0.00038	0.000708	CcSEcCtD
Phenazopyridine—Hypersensitivity—Prednisone—hematologic cancer	0.000373	0.000694	CcSEcCtD
Phenazopyridine—Dyspepsia—Methotrexate—hematologic cancer	0.000372	0.000693	CcSEcCtD
Phenazopyridine—Vomiting—Dexamethasone—hematologic cancer	0.000369	0.000688	CcSEcCtD
Phenazopyridine—Vomiting—Betamethasone—hematologic cancer	0.000369	0.000688	CcSEcCtD
Phenazopyridine—Rash—Dexamethasone—hematologic cancer	0.000366	0.000682	CcSEcCtD
Phenazopyridine—Rash—Betamethasone—hematologic cancer	0.000366	0.000682	CcSEcCtD
Phenazopyridine—Dermatitis—Dexamethasone—hematologic cancer	0.000366	0.000682	CcSEcCtD
Phenazopyridine—Dermatitis—Betamethasone—hematologic cancer	0.000366	0.000682	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000365	0.00068	CcSEcCtD
Phenazopyridine—Headache—Betamethasone—hematologic cancer	0.000364	0.000678	CcSEcCtD
Phenazopyridine—Headache—Dexamethasone—hematologic cancer	0.000364	0.000678	CcSEcCtD
Phenazopyridine—Pruritus—Prednisone—hematologic cancer	0.000358	0.000667	CcSEcCtD
Phenazopyridine—Dyspepsia—Epirubicin—hematologic cancer	0.000348	0.000649	CcSEcCtD
Phenazopyridine—Diarrhoea—Prednisone—hematologic cancer	0.000346	0.000645	CcSEcCtD
Phenazopyridine—Nausea—Dexamethasone—hematologic cancer	0.000345	0.000643	CcSEcCtD
Phenazopyridine—Nausea—Betamethasone—hematologic cancer	0.000345	0.000643	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000342	0.000636	CcSEcCtD
Phenazopyridine—Dyspepsia—Doxorubicin—hematologic cancer	0.000322	0.0006	CcSEcCtD
Phenazopyridine—Vomiting—Prednisone—hematologic cancer	0.000322	0.000599	CcSEcCtD
Phenazopyridine—Rash—Prednisone—hematologic cancer	0.000319	0.000594	CcSEcCtD
Phenazopyridine—Dermatitis—Prednisone—hematologic cancer	0.000319	0.000594	CcSEcCtD
Phenazopyridine—Headache—Prednisone—hematologic cancer	0.000317	0.00059	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000316	0.000589	CcSEcCtD
Phenazopyridine—Hypersensitivity—Methotrexate—hematologic cancer	0.000312	0.00058	CcSEcCtD
Phenazopyridine—Nausea—Prednisone—hematologic cancer	0.000301	0.00056	CcSEcCtD
Phenazopyridine—Pruritus—Methotrexate—hematologic cancer	0.000299	0.000557	CcSEcCtD
Phenazopyridine—Hypersensitivity—Epirubicin—hematologic cancer	0.000292	0.000543	CcSEcCtD
Phenazopyridine—Diarrhoea—Methotrexate—hematologic cancer	0.000289	0.000539	CcSEcCtD
Phenazopyridine—Pruritus—Epirubicin—hematologic cancer	0.00028	0.000521	CcSEcCtD
Phenazopyridine—Diarrhoea—Epirubicin—hematologic cancer	0.000271	0.000504	CcSEcCtD
Phenazopyridine—Hypersensitivity—Doxorubicin—hematologic cancer	0.00027	0.000502	CcSEcCtD
Phenazopyridine—Vomiting—Methotrexate—hematologic cancer	0.000269	0.000501	CcSEcCtD
Phenazopyridine—Rash—Methotrexate—hematologic cancer	0.000267	0.000497	CcSEcCtD
Phenazopyridine—Dermatitis—Methotrexate—hematologic cancer	0.000266	0.000496	CcSEcCtD
Phenazopyridine—Headache—Methotrexate—hematologic cancer	0.000265	0.000493	CcSEcCtD
Phenazopyridine—Pruritus—Doxorubicin—hematologic cancer	0.000259	0.000482	CcSEcCtD
Phenazopyridine—Vomiting—Epirubicin—hematologic cancer	0.000252	0.000469	CcSEcCtD
Phenazopyridine—Nausea—Methotrexate—hematologic cancer	0.000251	0.000468	CcSEcCtD
Phenazopyridine—Diarrhoea—Doxorubicin—hematologic cancer	0.000251	0.000467	CcSEcCtD
Phenazopyridine—Rash—Epirubicin—hematologic cancer	0.00025	0.000465	CcSEcCtD
Phenazopyridine—Dermatitis—Epirubicin—hematologic cancer	0.000249	0.000464	CcSEcCtD
Phenazopyridine—Headache—Epirubicin—hematologic cancer	0.000248	0.000462	CcSEcCtD
Phenazopyridine—Nausea—Epirubicin—hematologic cancer	0.000235	0.000438	CcSEcCtD
Phenazopyridine—Vomiting—Doxorubicin—hematologic cancer	0.000233	0.000434	CcSEcCtD
Phenazopyridine—Rash—Doxorubicin—hematologic cancer	0.000231	0.00043	CcSEcCtD
Phenazopyridine—Dermatitis—Doxorubicin—hematologic cancer	0.000231	0.00043	CcSEcCtD
Phenazopyridine—Headache—Doxorubicin—hematologic cancer	0.000229	0.000427	CcSEcCtD
Phenazopyridine—Nausea—Doxorubicin—hematologic cancer	0.000218	0.000405	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—CREB1—hematologic cancer	0.000142	0.000382	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CDK4—hematologic cancer	0.00014	0.000378	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MET—hematologic cancer	0.00014	0.000378	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MET—hematologic cancer	0.00014	0.000378	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CDK4—hematologic cancer	0.00014	0.000378	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NOTCH1—hematologic cancer	0.00014	0.000377	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NOTCH1—hematologic cancer	0.00014	0.000377	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PTPN11—hematologic cancer	0.00014	0.000377	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	0.000139	0.000376	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SRC—hematologic cancer	0.000139	0.000374	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6R—hematologic cancer	0.000138	0.000373	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—GRB2—hematologic cancer	0.000138	0.000372	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MET—hematologic cancer	0.000138	0.000372	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CREBBP—hematologic cancer	0.000138	0.000372	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—HRAS—hematologic cancer	0.000137	0.000369	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CREB1—hematologic cancer	0.000136	0.000365	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—VEGFA—hematologic cancer	0.000135	0.000364	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NOTCH1—hematologic cancer	0.000135	0.000364	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NOTCH1—hematologic cancer	0.000135	0.000364	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PTPN11—hematologic cancer	0.000134	0.000362	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PTPN11—hematologic cancer	0.000134	0.000362	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—STAT3—hematologic cancer	0.000134	0.00036	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—NRAS—hematologic cancer	0.000133	0.000359	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ABL1—hematologic cancer	0.000133	0.000358	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6R—hematologic cancer	0.000132	0.000356	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CREBBP—hematologic cancer	0.000132	0.000356	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MAP2K1—hematologic cancer	0.000132	0.000355	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—KRAS—hematologic cancer	0.000131	0.000353	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—IL6—hematologic cancer	0.000131	0.000353	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CREB1—hematologic cancer	0.00013	0.000351	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CREB1—hematologic cancer	0.00013	0.000351	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PTPN11—hematologic cancer	0.00013	0.000349	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PTPN11—hematologic cancer	0.00013	0.000349	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—SRC—hematologic cancer	0.000128	0.000345	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MAPK3—hematologic cancer	0.000128	0.000344	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—PTPN11—hematologic cancer	0.000128	0.000344	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—EP300—hematologic cancer	0.000127	0.000342	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6R—hematologic cancer	0.000127	0.000342	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6R—hematologic cancer	0.000127	0.000342	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CREBBP—hematologic cancer	0.000127	0.000342	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CREBBP—hematologic cancer	0.000127	0.000342	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MAP2K1—hematologic cancer	0.000126	0.00034	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HES1—hematologic cancer	0.000126	0.000339	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CREB1—hematologic cancer	0.000126	0.000338	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CREB1—hematologic cancer	0.000126	0.000338	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—FGF2—hematologic cancer	0.000125	0.000338	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NCOR1—hematologic cancer	0.000125	0.000337	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—VEGFA—hematologic cancer	0.000125	0.000336	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TGFB1—hematologic cancer	0.000124	0.000334	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—CREB1—hematologic cancer	0.000124	0.000333	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SRC—hematologic cancer	0.000124	0.000333	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—NRAS—hematologic cancer	0.000123	0.000332	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—SRC—hematologic cancer	0.000123	0.00033	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6R—hematologic cancer	0.000123	0.00033	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6R—hematologic cancer	0.000123	0.00033	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CREBBP—hematologic cancer	0.000122	0.00033	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CREBBP—hematologic cancer	0.000122	0.00033	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—HRAS—hematologic cancer	0.000122	0.000328	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—FOXO1—hematologic cancer	0.000122	0.000328	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MAP2K1—hematologic cancer	0.000121	0.000326	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MAP2K1—hematologic cancer	0.000121	0.000326	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6R—hematologic cancer	0.000121	0.000325	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—VEGFA—hematologic cancer	0.00012	0.000324	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—JAK2—hematologic cancer	0.00012	0.000324	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—FGF2—hematologic cancer	0.00012	0.000323	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TNF—hematologic cancer	0.00012	0.000322	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—VEGFA—hematologic cancer	0.000119	0.000322	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—JAK1—hematologic cancer	0.000119	0.000321	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—STAT3—hematologic cancer	0.000119	0.000321	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—NRAS—hematologic cancer	0.000119	0.00032	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MAPK3—hematologic cancer	0.000118	0.000318	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—NRAS—hematologic cancer	0.000118	0.000318	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—SRC—hematologic cancer	0.000118	0.000317	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SRC—hematologic cancer	0.000118	0.000317	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MAP2K1—hematologic cancer	0.000117	0.000315	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MAP2K1—hematologic cancer	0.000117	0.000315	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6—hematologic cancer	0.000117	0.000314	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—EP300—hematologic cancer	0.000116	0.000313	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TNF—hematologic cancer	0.000116	0.000312	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—FGF2—hematologic cancer	0.000115	0.00031	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—FGF2—hematologic cancer	0.000115	0.00031	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MAP2K1—hematologic cancer	0.000115	0.00031	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—JAK2—hematologic cancer	0.000115	0.00031	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—KRAS—hematologic cancer	0.000115	0.000309	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—VEGFA—hematologic cancer	0.000115	0.000309	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—VEGFA—hematologic cancer	0.000115	0.000309	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MAPK3—hematologic cancer	0.000114	0.000307	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—SRC—hematologic cancer	0.000114	0.000306	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—SRC—hematologic cancer	0.000114	0.000306	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—NRAS—hematologic cancer	0.000113	0.000305	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—NRAS—hematologic cancer	0.000113	0.000305	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SRC—hematologic cancer	0.000113	0.000305	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MAPK3—hematologic cancer	0.000113	0.000304	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—HRAS—hematologic cancer	0.000111	0.0003	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—FGF2—hematologic cancer	0.000111	0.000299	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—FGF2—hematologic cancer	0.000111	0.000299	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—VEGFA—hematologic cancer	0.000111	0.000298	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—VEGFA—hematologic cancer	0.000111	0.000298	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TGFB1—hematologic cancer	0.00011	0.000298	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—JAK2—hematologic cancer	0.00011	0.000297	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—JAK2—hematologic cancer	0.00011	0.000297	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—VEGFA—hematologic cancer	0.00011	0.000297	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—NRAS—hematologic cancer	0.000109	0.000294	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—NRAS—hematologic cancer	0.000109	0.000294	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—STAT3—hematologic cancer	0.000109	0.000294	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—NRAS—hematologic cancer	0.000109	0.000293	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MAPK3—hematologic cancer	0.000108	0.000292	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MAPK3—hematologic cancer	0.000108	0.000292	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—IL6—hematologic cancer	0.000107	0.000288	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—JAK2—hematologic cancer	0.000106	0.000287	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—JAK2—hematologic cancer	0.000106	0.000287	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—KRAS—hematologic cancer	0.000106	0.000286	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—JAK2—hematologic cancer	0.000105	0.000283	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MAPK3—hematologic cancer	0.000105	0.000282	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MAPK3—hematologic cancer	0.000105	0.000282	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MAPK3—hematologic cancer	0.000104	0.000281	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TNF—hematologic cancer	0.000103	0.000278	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—KRAS—hematologic cancer	0.000102	0.000276	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—KRAS—hematologic cancer	0.000101	0.000273	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TGFB1—hematologic cancer	0.000101	0.000272	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MAPK14—hematologic cancer	0.0001	0.00027	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CDK4—hematologic cancer	9.85e-05	0.000266	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MET—hematologic cancer	9.85e-05	0.000266	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—HRAS—hematologic cancer	9.76e-05	0.000263	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—KRAS—hematologic cancer	9.75e-05	0.000263	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—KRAS—hematologic cancer	9.75e-05	0.000263	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL6—hematologic cancer	9.65e-05	0.00026	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NOTCH1—hematologic cancer	9.49e-05	0.000256	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TNF—hematologic cancer	9.44e-05	0.000254	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—EP300—hematologic cancer	9.4e-05	0.000253	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—KRAS—hematologic cancer	9.4e-05	0.000253	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—KRAS—hematologic cancer	9.4e-05	0.000253	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—KRAS—hematologic cancer	9.36e-05	0.000252	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—IL6—hematologic cancer	9.34e-05	0.000252	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SRC—hematologic cancer	9.14e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PTPN11—hematologic cancer	9.11e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—HRAS—hematologic cancer	9.02e-05	0.000243	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—EP300—hematologic cancer	8.99e-05	0.000242	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—VEGFA—hematologic cancer	8.9e-05	0.00024	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CREB1—hematologic cancer	8.83e-05	0.000238	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—STAT3—hematologic cancer	8.82e-05	0.000238	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—NRAS—hematologic cancer	8.8e-05	0.000237	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SRC—hematologic cancer	8.74e-05	0.000236	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—HRAS—hematologic cancer	8.7e-05	0.000234	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—EP300—hematologic cancer	8.64e-05	0.000233	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—EP300—hematologic cancer	8.64e-05	0.000233	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6—hematologic cancer	8.63e-05	0.000233	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—HRAS—hematologic cancer	8.62e-05	0.000232	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT1—hematologic cancer	8.62e-05	0.000232	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6R—hematologic cancer	8.61e-05	0.000232	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CREBBP—hematologic cancer	8.6e-05	0.000232	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—VEGFA—hematologic cancer	8.52e-05	0.000229	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—STAT3—hematologic cancer	8.43e-05	0.000227	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MAPK3—hematologic cancer	8.42e-05	0.000227	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—NRAS—hematologic cancer	8.41e-05	0.000227	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SRC—hematologic cancer	8.4e-05	0.000226	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SRC—hematologic cancer	8.4e-05	0.000226	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—EP300—hematologic cancer	8.33e-05	0.000224	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—EP300—hematologic cancer	8.33e-05	0.000224	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6—hematologic cancer	8.33e-05	0.000224	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—HRAS—hematologic cancer	8.29e-05	0.000223	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—HRAS—hematologic cancer	8.29e-05	0.000223	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6—hematologic cancer	8.25e-05	0.000222	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MAP2K1—hematologic cancer	8.21e-05	0.000221	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—VEGFA—hematologic cancer	8.18e-05	0.00022	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—VEGFA—hematologic cancer	8.18e-05	0.00022	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TGFB1—hematologic cancer	8.17e-05	0.00022	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—STAT3—hematologic cancer	8.1e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—STAT3—hematologic cancer	8.1e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SRC—hematologic cancer	8.1e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SRC—hematologic cancer	8.1e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NRAS—hematologic cancer	8.08e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NRAS—hematologic cancer	8.08e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MAPK3—hematologic cancer	8.06e-05	0.000217	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—HRAS—hematologic cancer	7.99e-05	0.000215	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—HRAS—hematologic cancer	7.99e-05	0.000215	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—SRC—hematologic cancer	7.98e-05	0.000215	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—HRAS—hematologic cancer	7.96e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—IL6—hematologic cancer	7.93e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6—hematologic cancer	7.93e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—VEGFA—hematologic cancer	7.89e-05	0.000213	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—VEGFA—hematologic cancer	7.89e-05	0.000213	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TGFB1—hematologic cancer	7.82e-05	0.000211	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—STAT3—hematologic cancer	7.81e-05	0.000211	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—STAT3—hematologic cancer	7.81e-05	0.000211	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—FGF2—hematologic cancer	7.81e-05	0.00021	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NRAS—hematologic cancer	7.79e-05	0.00021	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NRAS—hematologic cancer	7.79e-05	0.00021	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—VEGFA—hematologic cancer	7.77e-05	0.000209	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MAPK3—hematologic cancer	7.74e-05	0.000209	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MAPK3—hematologic cancer	7.74e-05	0.000209	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT1—hematologic cancer	7.68e-05	0.000207	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—NRAS—hematologic cancer	7.68e-05	0.000207	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6—hematologic cancer	7.65e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6—hematologic cancer	7.65e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TNF—hematologic cancer	7.63e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6—hematologic cancer	7.62e-05	0.000205	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KRAS—hematologic cancer	7.57e-05	0.000204	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TGFB1—hematologic cancer	7.51e-05	0.000202	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TGFB1—hematologic cancer	7.51e-05	0.000202	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—JAK2—hematologic cancer	7.48e-05	0.000202	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MAPK3—hematologic cancer	7.46e-05	0.000201	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MAPK3—hematologic cancer	7.46e-05	0.000201	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MAPK3—hematologic cancer	7.35e-05	0.000198	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TNF—hematologic cancer	7.3e-05	0.000197	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TGFB1—hematologic cancer	7.24e-05	0.000195	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TGFB1—hematologic cancer	7.24e-05	0.000195	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—KRAS—hematologic cancer	7.24e-05	0.000195	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT1—hematologic cancer	7.03e-05	0.000189	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TNF—hematologic cancer	7.01e-05	0.000189	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TNF—hematologic cancer	7.01e-05	0.000189	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KRAS—hematologic cancer	6.96e-05	0.000187	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KRAS—hematologic cancer	6.96e-05	0.000187	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TNF—hematologic cancer	6.76e-05	0.000182	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TNF—hematologic cancer	6.76e-05	0.000182	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KRAS—hematologic cancer	6.71e-05	0.000181	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KRAS—hematologic cancer	6.71e-05	0.000181	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KRAS—hematologic cancer	6.61e-05	0.000178	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—HRAS—hematologic cancer	6.43e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6—hematologic cancer	6.16e-05	0.000166	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—HRAS—hematologic cancer	6.15e-05	0.000166	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—HRAS—hematologic cancer	5.91e-05	0.000159	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HRAS—hematologic cancer	5.91e-05	0.000159	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6—hematologic cancer	5.89e-05	0.000159	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—EP300—hematologic cancer	5.86e-05	0.000158	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—HRAS—hematologic cancer	5.7e-05	0.000154	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HRAS—hematologic cancer	5.7e-05	0.000154	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SRC—hematologic cancer	5.7e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT1—hematologic cancer	5.68e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6—hematologic cancer	5.66e-05	0.000152	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6—hematologic cancer	5.66e-05	0.000152	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—HRAS—hematologic cancer	5.62e-05	0.000151	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VEGFA—hematologic cancer	5.55e-05	0.000149	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—STAT3—hematologic cancer	5.49e-05	0.000148	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NRAS—hematologic cancer	5.48e-05	0.000148	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6—hematologic cancer	5.46e-05	0.000147	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6—hematologic cancer	5.46e-05	0.000147	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT1—hematologic cancer	5.43e-05	0.000146	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6—hematologic cancer	5.38e-05	0.000145	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MAPK3—hematologic cancer	5.25e-05	0.000141	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT1—hematologic cancer	5.22e-05	0.000141	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT1—hematologic cancer	5.22e-05	0.000141	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TGFB1—hematologic cancer	5.09e-05	0.000137	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT1—hematologic cancer	5.03e-05	0.000136	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT1—hematologic cancer	5.03e-05	0.000136	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TNF—hematologic cancer	4.75e-05	0.000128	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KRAS—hematologic cancer	4.72e-05	0.000127	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HRAS—hematologic cancer	4.01e-05	0.000108	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6—hematologic cancer	3.84e-05	0.000103	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT1—hematologic cancer	3.54e-05	9.54e-05	CbGpPWpGaD
